The upcoming GPT Healthcare IPO marks a pivotal moment for investors with an eye on the healthcare industry. This significant event highlights the growing investment opportunities within the sector and showcases GPT Healthcare's ambition to expand its footprint and enhance its services. Given the company's promising outlook and strategic position in the healthcare market, the IPO is poised to attract substantial interest.
| Parameter | Details |
|---|---|
| Open Date | 22-Feb-24 |
| Close Date | 26-Feb-24 |
| Lot Size | 80 shares |
| IPO Size | 525.14 Cr |
| IPO Price Range | 177 to 186 |
| Min Investment | 14,160.00 |
| Listing Exchange | BSE, NSE |
| Basis of Allotment | 27-Feb-24 |
| Refunds | 28-Feb-24 |
| Credit to Demat Account | 28-Feb-24 |
| Listing Date | 29-Feb-24 |
Checkout the List of Upcoming IPO.
GPT Healthcare is set to debut publicly with an IPO that opens on February 22, 2024 and closes on February 26, 2024. The offering includes a lot size of 80 shares, with the IPO size pegged at 525.14 Cr. The price range for the IPO is set between 177 and 186, making the minimum investment 14,160.
The shares will be listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE), providing wide visibility and accessibility to investors. The timeline for the IPO process is laid out, with the basis of allotment scheduled for February 27, refunds on February 28, credit to Demat accounts also on February 28, and the listing date on February 29, 2024.
Founded in 1989, GPT Healthcare has grown to become a leading corporate healthcare provider in the Eastern region of India. The company operates a chain of mid-sized, comprehensive service hospitals under the ILS Hospitals brand, delivering various healthcare services emphasising secondary and tertiary care.
As of September 2023, GPT Healthcare runs four multispecialty hospitals in Dum Dum, Salt Lake, Howrah in West Bengal, and Agartala in Tripura, containing 561 beds. The company is dedicated to providing healthcare solutions in Eastern India, a region typically underserved in this sector.
GPT Healthcare offers an extensive range of over 35 specialities and super specialities, encompassing internal medicine, diabetology, nephrology (including renal transplants), laparoscopic and general surgery, gynaecology and obstetrics, critical care, gastroenterology, orthopaedics and joint replacements, interventional cardiology, neurology, neurosurgery, paediatrics, and neonatology.
GPT Healthcare has demonstrated robust financial performance over the past three fiscal years. The company's revenue from operations saw a steady increase, from Rs. 242.75 crores in FY21 to Rs. 361.03 crores in FY23. EBITDA and PAT have also shown positive trends, indicating efficient operational management and profitability. The financial health of GPT Healthcare is further underscored by its solid asset base and prudent cash flow management.
| Particulars (in Rs. Crores) | FY23 | FY22 | FY21 |
|---|---|---|---|
| Revenue from Operations | 361.03 | 337.41 | 242.75 |
| EBITDA | 80.04 | 78.82 | 55.1 |
| PAT | 39.00 | 41.66 | 21.09 |
| Total Assets | 326.75 | 323.22 | 317.21 |
| Share Capital | 79.90 | 79.90 | 17.94 |
| Total Borrowings | 161.39 | 165.04 | 183.31 |
| Net Cash from Operating Activities | 66.35 | 65.99 | 43.92 |
| Net Cash from Investing Activities | 5.15 | -5.33 | -17.38 |
| Net Cash from Financing Activities | -73.17 | -57.16 | -22.11 |
| Net Increase in Cash | -1.66 | 3.49 | 4.43 |
| Strengths | Weaknesses |
|---|---|
| Market Position: The company holds a strong market position, enjoying a significant share in its niche. Its products or services are well-regarded and have a loyal customer base. This competitive advantage gives the company pricing power and enhances its ability to attract and retain customers. | Operational Risks: The company faces operational risks related to supply chain disruptions, technology failures, or human error. Mitigating these risks requires thorough contingency planning and robust operational processes. |
| Market Competition: The market is highly competitive, with numerous players vying for market share. This intense competition can pressure profit margins and necessitate constant innovation and marketing efforts to stay ahead of rivals. | Growth Potential: The company has limited growth potential in its current market or industry. To expand further, it may need to diversify its products or services, target new market segments, or explore international markets. |
| Financial Stability: The company's financials are robust, with healthy revenue, profitability, and cash flow. This stability instils investor confidence and provides a solid foundation for future growth initiatives. | Regulatory Challenges: The company operates in a heavily regulated industry, facing compliance and legal challenges. Navigating these regulations requires a dedicated compliance team and an understanding of regulatory changes and updates. |
A simple and smartest way to Apply in IPO online via Religare Dynami Mobile App
Retail investors need to apply for the IPO using UPI
Fill up your personal details in the form above
Fill up your DOB, PAN, email & bank account details
Upload your photo and e-sign your application via Aadhaar OTP
An IPO also known as initial pulic offering or stock launch is a process when a private company sale its shares to public for the first time. Learn more about IPO at our knowledge centre.
A lot size is the minimum number of shares that an investor has to bid for. A lot size differs for each IPO and is fixed by the company.
IPO Price Band is the price range within which investors can bid for the shares. The minimum price is called the floor price and the maximum price is called the cap price.
Issue size is the total value of an IPO. It is calculated by multiplying the number of shares offered by the company by the issue price per share.
You will receive an email on your registered email id if the IPO shares are allotted to you. Alternatively, you can also visit the registrar of the company’s official website and provide the details as asked in the allotment status section of the website.
IPOs, as such, do not have any taxes. You are taxed only when you decide to sell the IPO shares. Any monetary profit you make while selling the IPO shares is referred to as ‘capital gains’.
Capital gains tax is charged depending on how long you held the shares for. If you owned the shares for less than 12 months, it is considered as short-term capital gains and if it is over 12 months, it is referred as long-term capital gains.
Tax on short-term capital gains is 15%. It is 10% for equity gains in the long run (over 12 months). Do remember that you are taxed if the equity proceeds exceed Rs 1 lakh.
The price band of GPT Healthcare IPO is set at Rs. 177 to Rs. 186 per share.
The size of GPT Healthcare IPO is 525.14 cr.
The minimum lot size of GPT Healthcare's IPO is 80 shares, and the minimum investment required to apply for the IPO is Rs. 14,160.
Copyright 2010 Religare. Trademarks are the property of their respective owners. All rights
reserved. Please note that by submitting your mobile and email on our website, you are
authorizing us to Call/SMS/Whtsapp/RCS/Email you even though you may be registered under DNC. We
shall Call/SMS you for a period of 12 months.
Religare Broking Limited (RBL): Registered Office: 2nd Floor, P-14, 45/90, P-Block, Connaught
Place, New Delhi 110001. Board line number: 011-49871213. Fax No.: 011-49871189
Religare Broking Limited: SEBI Regn. No. INZ000174330 NSE CM, F&O, CD TM Code: 06537 Clearing
Member (F&O) No. M50235; BSE CM, F&O, CD, CO TM Code: 3004 Clearing No: 3004; MSE CM, F&O, CD,
TM Code: 1051 | MCX Membership No. 56560 | NCDEX Membership No. 01276 | AMFI ARN No.139809.
Depository Participant: NSDL: DP ID: IN 301774 | CDSL DP ID: 30200 - SEBI Regn. No:
IN-DP-385-2018. | Research Analyst Regn.No: INH100006977 | PFRDA POP registration No. 01092018 |
IRDA Corporate Agent
Registration No: CA0581 | Company CIN : U65999DL2016PLC314319.
Disclaimer : Investment in securities market are subject to market risks, read all the related
documents carefully before investing. RBL is a distributor of Mutual Funds / IPOs / Insurance /
Bonds & NCDs. Equities, Currencies & Depository Services are offered through Religare Broking
Ltd.
To remain updated on the latest market updates follow us at
